Cellebrite Di Ltd (CLBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 124,457 | 191,659 | 189,517 | 87,645 | 145,973 |
| Marketable Securities | 312,593 | 255,564 | 113,406 | 95,978 | 35,592 |
| Receivables | 104,972 | 82,358 | 77,269 | 78,761 | 67,505 |
| Inventories | 7,603 | 8,939 | 9,940 | 10,176 | 6,511 |
| Other current assets | 6,595 | 5,827 | 5,550 | 6,286 | 4,813 |
| TOTAL | $575,850 | $567,593 | $422,082 | $295,931 | $273,212 |
| Non-Current Assets | |||||
| PPE Net | 22,209 | 16,995 | 15,896 | 17,259 | 16,756 |
| Investments And Advances | 97,959 | 36,601 | 28,859 | 22,125 | 0 |
| Intangibles | 201,028 | 40,020 | 37,423 | 38,083 | 38,057 |
| Other Non-Current Assets | 41,806 | 29,358 | 28,625 | 29,895 | 11,758 |
| TOTAL | $363,002 | $122,974 | $110,803 | $107,362 | $66,571 |
| Total Assets | $938,852 | $690,567 | $532,885 | $403,293 | $339,783 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 88,078 | 74,407 | 53,127 | 50,065 | 63,590 |
| TOTAL | $369,657 | $295,502 | $253,824 | $207,777 | $186,573 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 277,583 | 216,970 | 195,725 | 152,709 | 122,983 |
| Other Non-Current Liabilities | 35,351 | 13,798 | 197,751 | 79,478 | 190,131 |
| TOTAL | $84,877 | $59,045 | $244,849 | $121,651 | $226,557 |
| Total Liabilities | $454,534 | $354,547 | $498,673 | $329,428 | $413,130 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 188,541 |
| Retained earnings | -86,538 | -164,864 | 118,143 | 199,243 | 78,438 |
| Other shareholders' equity | 2,135 | 2,001 | 965 | 246 | 1,287 |
| TOTAL | $484,318 | $336,020 | $34,212 | $73,865 | $-73,347 |
| Total Liabilities And Equity | $938,852 | $690,567 | $532,885 | $403,293 | $339,783 |